Evolution of nerve fiber degeneration in the striatum in the MPTP-treated squirrel monkey
- PMID: 7888093
- DOI: 10.1007/BF02816116
Evolution of nerve fiber degeneration in the striatum in the MPTP-treated squirrel monkey
Abstract
We have examined the ultrastructure of the striatum in squirrel monkeys 1-5 d after a single sc injection of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) 2.5 mg/kg. One untreated monkey served as control. We expected to find a dense degeneration of the dopamine terminals, but found instead that the main abnormality consisted of a focal vacuolation of the tissue, perhaps related to the striosome/matrix mosaic of the neostriatum. The vacuolation involved not only terminals, but also other parts of the neuropil. The severity of the destructive process increased from d 1-5. We conclude that MPP+, the toxic metabolite of MPTP, may gain access to the neuropil, either before or after its active uptake into and subsequent destruction of the dopamine terminals. In the present study, abnormalities were observed simultaneously in the striatum and substantia nigra as early as 24 h after MPTP administration. It is, however, possible that the time-course might differ between the two locations with even shorter time intervals or changes in dosage of MPTP.
Similar articles
-
Early-stage loss of dopamine uptake-site binding in MPTP-treated monkeys.Adv Neurol. 1993;60:34-9. Adv Neurol. 1993. PMID: 8420148 No abstract available.
-
Chronic administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine to monkeys: behavioural, morphological and biochemical correlates.Neuroscience. 1993 Aug;55(3):823-32. doi: 10.1016/0306-4522(93)90444-k. Neuroscience. 1993. PMID: 8105418
-
Relationship among nigrostriatal denervation, parkinsonism, and dyskinesias in the MPTP primate model.Mov Disord. 2000 May;15(3):459-66. doi: 10.1002/1531-8257(200005)15:3<459::AID-MDS1006>3.0.CO;2-3. Mov Disord. 2000. PMID: 10830409
-
The actions of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in animals as a model of Parkinson's disease.J Neural Transm Suppl. 1986;20:11-39. J Neural Transm Suppl. 1986. PMID: 3091760 Review.
-
Metabolic aspects of the behavior of MPTP and some analogues.Adv Neurol. 1993;60:186-93. Adv Neurol. 1993. PMID: 8420134 Review. No abstract available.
Cited by
-
Pathologic modifications of alpha-synuclein in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated squirrel monkeys.J Neuropathol Exp Neurol. 2008 Aug;67(8):793-802. doi: 10.1097/NEN.0b013e318180f0bd. J Neuropathol Exp Neurol. 2008. PMID: 18648323 Free PMC article.